Savara Inc. announced that Badrul Chowdhury, M.D., Ph.D., has resigned from his role as Chief Medical Officer, effective September 9, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | -1.96% | -3.01% | -14.36% |
05-21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
05-09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.36% | 565M | |
+14.37% | 118B | |
+12.75% | 106B | |
-3.48% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.66% | 15.56B | |
+4.06% | 13.63B | |
+28.19% | 12.27B |
- Stock Market
- Equities
- SVRA Stock
- News Savara Inc.
- Savara Announces Resignation of Badrul Chowdhury as Chief Medical Officer, Effective on September 9, 2022